Note: This news item is more than a year old. Browse for more current news.
Lovelace Medical Center Earns Award for Stroke Care
Albuquerque, NM (Feb. 21) - Lovelace Medical Center received the American Heart Association/American Stroke Association’s Get With The Guidelines®–Stroke Gold Plus Quality Achievement Award.
February 29, 2012
The award recognizes Lovelace Medical Center’s commitment and success in implementing a higher standard of stroke care by ensuring that stroke patients receive treatment according to nationally accepted standards and recommendations.
Lovelace Medical Center achieved 85 percent or higher adherence to all Get With The Guidelines-Stroke Quality Achievement indicators for two or more consecutive 12-month intervals. These measures include aggressive use of medications, such as antithrombotics, anticoagulation therapy, deep vein thrombosis prophylaxis, cholesterol reducing drugs and smoking cessation, all aimed at reducing death and disability and improving the lives of stroke patients.
In addition to the Get With The Guideline-Stroke award Lovelace Medical Center has also been recognized as a recipient of the association’s Target: Stroke Honor Roll, for improving stroke care. Over the past quarter, at least 50 percent of the hospital’s eligible ischemic stroke patients have received tissue plasminogen activator, or tPA, within 60 minutes of arriving at the hospital (known as ‘door-to-needle’ time). A thrombolytic, or clot-busting agent, tPA is the only drug approved by the U.S. Food and Drug Administration for the urgent treatment of ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reverse the effects of stroke and reduce permanent disability.